Lymphoma Program


Abramson Cancer Center lymphoma clinicians and researchers have led the way nationally for years in the diagnosis and treatment of lymphomas.

Today, there's more hope than ever for those diagnosed with lymphoma. Our team has worked together for years. By putting our experience to work, we offer the best possible treatment outcomes.

If diagnosed with lymphoma, it's important to have the best team of experts available.

At Penn's Lymphoma Program there are individuals nationally recognized for their expertise. They can provide the information, care and support to help each step of the way.

Penn has one of the few Hematologic Malignancy (leukemia, lymphoma and myeloma) Research Programs in the country that is approved and funded by the National Cancer Institute.

The knowledge gained through our research allows us to better care for those with lymphoma.

Survivor Stories

Brian Trainor

It was on January 7th that Penn law student Brian Trainor, a healthy and active 31 year old with no known symptoms had a sudden seizure. Brian was rushed to HUP, where he received a CT scan and MRI, which uncovered a 2.5 centimeter tumor on the left frontal lobe of his brain.




Spotlight

Learn about CAR T Cell Trials at Penn

Media Hub for Bone Marrow Transplant and Stem Cell Transplant

Media Hub for Leukemia, Lymphoma and Myeloma - Watch Educational Videos!

Focus On Blood Cancers and Bone Marrow Transplant Video
A patient education video with testimonies from our patients, doctors and researchers. Find out more about programs, treatment, research and care that is unique to the Abramson Cancer Center.



Clinical Trials

Clinical trials are studies to find new ways to prevent, detect and treat cancer. The purpose of each clinical trial is to answer a specific question. Our physicians carefully design these studies to find new ways to improve care and quality of life ... more about clinical trials